Bristol-Myers Squibb Co
Composite intelligence score across six weighted factors. Higher score = stronger composite signal.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Insider · Congress · Wall Street flow
- · Pro Chart event markers
- · Score history + alerts
Composite trend over time
Why is BMY moving today?
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
BMY contract awards, year to date.
Public federal awards linked to this ticker.
BREYANZI CAR-T
BREYANZI CAR-T TRANSPLANT.
BREYANZI CAT-T TRANSPLANT
BREYANZI CAR T-TRANSPLANT
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)
BMY lobbying filings, year to date.
Registered lobbying filings matched to Bristol-Myers Squibb Co.
BRISTOL-MYERS SQUIBB COMPANY
BRISTOL-MYERS SQUIBB COMPANY
THE MCMANUS GROUP